About
About Dong Sung Bio Pharm.Co.,Ltd
Dong Sung Bio Pharm.Co.,Ltd. manufactures and sells pharmaceuticals and cosmetics in South Korea. The company offers over the counter drugs, such as emollient, vitamin supplement, alopecia treatment, antihistamines, liver disease treatment, fire extinguisher solvent, antiviral, eye drops, menopause treatment, sleep inducer, antipyretic, analgesic, anti-inflammatory, vascular reinforcement, broad-spectrum skin disease treatment, gum disease treatment, blood circulation improver, scar treatment, dry stomach, eye nourishment, abdominal obesity treatment, anti-soil agent, respiratory solvent, and antifungal agent. It also provides prescription drugs, including endocrine system, corticosteroids, fire extinguishing system, circulatory system, psychotropic solvents, tumor therapy, analgesic anti-inflammatory, cutaneous urinary system, antiviral, antibiotics, and respiratory system. In addition, the company offers hair dye, cosmetics, health functional supplements, nasal spray, household goods, muscle taping, disinfectant, toothpaste, anti-hair loss shampoo, and sanitary napkin. The company was founded in 1957 and is headquartered in Seoul, South Korea.
Research context
Dong Sung Bio Pharm.Co.,Ltd appears in PyInvesting’s Korea Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- KRW
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Visit company website
5 years, 6 months ago
Dong Sung Bio Pharm.Co.,Ltd is currently in a long term downtrend where the price is trading 14.4% below its 200 day moving average.
From a valuation standpoint, the stock is 63.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.1.
Dong Sung Bio Pharm.Co.,Ltd's total revenue sank by 9.2% to $19B since the same quarter in the previous year.
Its net income has dropped by 36.7% to $-7B since the same quarter in the previous year.
Finally, its free cash flow grew by 102.4% to $142M since the same quarter in the previous year.
Based on the above factors, Dong Sung Bio Pharm.Co.,Ltd gets an overall score of 2/5.